Your account is not claimed yet. You can sign up with ORCID to claim your account.

Samuel W Terman

ORCID

Publication Activity (10 Years)

Years Active: 2021-2023
Publications (10 Years): 24

Top Venues

This page only lists publications with an associated author ORCID identifier.

Publications

Samuel W Terman, Hélène E Aschmann, David W Hutton, James F Burke
Best-worst scaling preferences among patients with well-controlled epilepsy: Pilot results. PloS one 18 (3) (2023)
Samuel W Terman
Making Up Missed Anti-Seizure Medication Doses: Double or Nothing? Epilepsy currents 23 (4) (2023)
Samuel W Terman, Hélène E Aschmann, David W Hutton, James F Burke
Best-worst scaling preferences among patients with well-controlled epilepsy: Pilot results. PloS one 18 (3) (2023)
Samuel W Terman, Hélène E Aschmann, David W Hutton, James F Burke
Best-worst scaling preferences among patients with well-controlled epilepsy: Pilot results. PloS one 18 (3) (2023)
Samuel W Terman, Renate van Griethuysen, Carole E Rheaume, Geertruida Slinger, Anisa S Haque, Shawna N Smith, Wesley T Kerr, Charlotte van Asch, Willem M Otte, Carolina Ferreira-Atuesta, Marian Galovic, James F Burke, Kees Pj Braun
Antiseizure medication withdrawal risk estimation and recommendations: a survey of American Academy of Neurology and EpiCARE members. Epilepsia open (2023)
Chloe E Hill, Chun Chieh Lin, Samuel W Terman, Darin Zahuranec, Jack M Parent, Lesli E Skolarus, James F Burke
Predictors of Referral for Long-term EEG Monitoring for Medicare Beneficiaries with Drug-Resistant Epilepsy. Epilepsia open (2023)
Samuel W Terman, Geertruida Slinger, Adriana Koek, Jeremy Skvarce, Mellanie V Springer, Julie M Ziobro, James F Burke, Willem M Otte, Roland D Thijs, Kees P J Braun
Frequency of and factors associated with antiseizure medication discontinuation discussions and decisions in patients with epilepsy: A multicenter retrospective chart review. Epilepsia open (2023)
Samuel W Terman, Hélène E Aschmann, David W Hutton, James F Burke
Best-worst scaling preferences among patients with well-controlled epilepsy: Pilot results. PloS one 18 (3) (2023)
Samuel W Terman, Joshua D Niznik, Matthew E Growdon, Lauren B Gerlach, James F Burke
Secular Trends in Central Nervous System-Active Polypharmacy Among Serial Cross-Sections of US Adults, 2009-2020. Drugs & aging (2023)
Samuel W Terman, Renate van Griethuysen, Carole E Rheaume, Geertruida Slinger, Anisa S Haque, Shawna N Smith, Wesley T Kerr, Charlotte van Asch, Willem M Otte, Carolina Ferreira-Atuesta, Marian Galovic, James F Burke, Kees P J Braun
Antiseizure medication withdrawal risk estimation and recommendations: A survey of American Academy of Neurology and EpiCARE members. Epilepsia open (2023)
Samuel W Terman, Hélène E Aschmann, David W Hutton, James F Burke
Best-worst scaling preferences among patients with well-controlled epilepsy: Pilot results. PloS one 18 (3) (2023)
Samuel W Terman, Geertruida Slinger, Adriana Koek, Jeremy Skvarce, Mellanie V Springer, Julie M Ziobro, James F Burke, Willem M Otte, Roland D Thijs, Kees Pj Braun
Frequency of and factors associated with antiseizure medication discontinuation discussions and decisions in patients with epilepsy: a multicenter retrospective chart review. Epilepsia open (2023)
Samuel W Terman, Geertruida Slinger, Adriana Koek, Jeremy Skvarce, Mellanie V Springer, Julie M Ziobro, James F Burke, Willem M Otte, Roland D Thijs, Kees P J Braun
Frequency of and factors associated with antiseizure medication discontinuation discussions and decisions in patients with epilepsy: A multicenter retrospective chart review. Epilepsia open (2023)
Samuel W Terman
Choose Your Own Adventure: Expert Advice at Your Fingertips. Epilepsy currents 22 (1) (2022)
Samuel W Terman
Deep Thoughts-Predicting Initial Treatment Response in Newly Diagnosed Epilepsy. Epilepsy currents 23 (2) (2022)
Samuel W Terman
Deep Thoughts-Predicting Initial Treatment Response in Newly Diagnosed Epilepsy. Epilepsy currents 23 (2) (2022)
Samuel W Terman, Chang Wang, Lu Wang, Kees P J Braun, Willem M Otte, Geertruida Slinger, Wesley T Kerr, Morten I Lossius, Laura Bonnett, James F Burke, Anthony G Marson
Reappraisal of the Medical Research Council Antiepileptic Drug Withdrawal Study: Contamination-adjusted and dose-response re-analysis. Epilepsia 63 (7) (2022)
Samuel W Terman, Brett E Youngerman, Hyunmi Choi, James F Burke
Antiseizure medication treatment pathways for US Medicare beneficiaries with newly treated epilepsy. Epilepsia 63 (6) (2022)
Samuel W Terman
Women With Epilepsy: Causes for Concern. Epilepsy currents 23 (1) (2022)
Samuel W Terman, Herm J Lamberink, Geertruida Slinger, Willem M Otte, James F Burke, Kees P J Braun
Is the crystal ball broken? Another external validation of the post-withdrawal seizure-relapse prediction model. Epilepsia 62 (12) (2021)
Samuel W Terman, James F Burke
Use of item response theory to investigate disability-related questions in the National Health and Nutrition Examination Survey. SAGE open medicine 9 (2021)
Samuel W Terman
Dollars and Sense: Cost-Effectiveness of Epilepsy Surgery. Epilepsy currents 21 (3) (2021)
Samuel W Terman
Risky Business: Traumatic Brain Injury and Epilepsy. Epilepsy currents 21 (4) (2021)
Samuel W Terman, Wesley T Kerr, Zachary A Marcum, Lu Wang, James F Burke
Antiseizure medication adherence trajectories in Medicare beneficiaries with newly treated epilepsy. Epilepsia 62 (11) (2021)

Samuel W Terman.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Samuel W Terman